show that a,-AT is also a product of Paneth cells. Together with the results of other studies, these data raise the possibility that a,-AT detected in fecal a,-AT clearance assays for diagnosing protein-losing enteropathies is predominantly derived from sloughed enterocytes. (J. Clin. Invest. 1993. 92:2022-2034
Introduction a1-Antitrypsin (a,-AT)' is a -55-kD glycoprotein, an acute phase plasma protein, and prototype serine proteinase inhibitor (serpin), which inhibits neutrophil elastase. Genetic and acquired forms of a,-AT deficiency are associated with premature development of emphysema. The most common genetic form ofa I-AT deficiency, homozygous PiZZ aI-AT deficiency, is also associated with chronic liver disease and hepatocellular carcinoma (1) .
Studies of changes in a,-AT allotypes after orthotopic liver transplantation have shown that liver is the predominant site of synthesis of blood-borne a,-AT (2, 3) . There is evidence for extrahepatic sites ofsynthesis, notably that in blood monocytes and tissue macrophages (4) . Results oftransgenic mice studies have suggested that the human al-AT gene is expressed in other extrahepatic tissues and cell types (5, 6) . For instance, RNA blot analysis has demonstrated the presence of a,-AT mRNA in the small intestine of mice transgenic for human a,-AT and in human small intestine (5, 7) . These studies did not, however, exclude the possibility that such a,-AT mRNA was derived from macrophages resident in the lamina propria or submucosal layers of the intestine. Synthesis of a,-AT has been demonstrated in a human intestinal adenocarcinoma cell line Caco2 (8) . There is a marked increase in synthesis of a,-AT in Caco2 cells as they spontaneously differentiate from cryptlike to villouslike enterocytes. It could be argued, however, that expression of a,-AT in Caco2 cells is a result ofthe transformation ofthese cells and not necessarily a reflection ofthe physiological function of enterocytes in vivo. Ribonuclease protection assays designed to map transcriptional initiation sites for a,-AT mRNA indicate that the predominant a,-AT mRNA in jejunum is similar to that of Caco2-derived enterocytes and HepG2-derived hepatocytes, and entirely distinct from the alternative upstream transcriptional sites used in blood monocytes and bronchoalveolar macrophages (7) . However, these results do not exclude the possibility that intestinal macrophages use the downstream transcriptional initiation site. In the current study, we subjected specimens of human intestine to in situ hybridization analysis to definitively determine that the a,-AT gene is expressed in enterocytes and to examine other cell-specific sites of a,-AT gene expression in intestinal epithelium.
Methods
Materials. Ribonuclease A was purchased from Sigma Chemical Co.
(St. Louis, MO), ribonuclease Tl was purchased from Bethesda Research Laboratories (Gaithersburg, MD), and DNAse I and ribonuclease inhibitor were purchased from Promega Biotech (Madison, WI).
35S-UTP and [32P]CTP were purchased from Du Pont-New England Nuclear (Boston, MA).
Cell culture. Primary cultures of human peripheral blood monocytes were established according to previously described methods (8) .
Maintenance of Caco2 cells has also been previously described (9) .
Ribonuclease protection assays. The DNA probe used (probe C) is a 158-bp BamHI-BamHI fragment derived from L17.3 and spanning the hepatocyte-specific transcriptional initiation site that had been subcloned into the pGEM4z plasmid (7) . For protection assays, 32P-labeled antisense complementary RNA probe C was synthesized using linearized plasmid (5 jig), [32P] CTP (50 ,Ci), and SP6 RNA polymerase. From this reaction mixture, 1/1,000 of the final product was allowed to hybridize overnight to 10 gg total cellular RNA in 50% form-amide at 550C. RNAse digestion was performed at room temperature with RNAse A and T1, and the protected fragments were separated on 6% polyacrylamide gels.
In situ hybridization. Jejunal, ileal, and colonic tissue was obtained from two different organ donors through Mid America Transplant Association (St. Louis, MO). These studies were approved by the Human Studies Committee of Washington University School of Medicine. Ileal tissue from three patients with Crohn's disease was obtained at the time of ileocolonic resection. Sections of ileum with active inflammation were compared to adjacent uninflamed sections from each patient. In situ hybridization was performed as previously described (10) with the following modifications: immediately after harvesting, tissues were divided into 2-cm-long fragments and snap-frozen in liquid nitrogen.
Cryostat sections (5-8 gm) of tissue were fixed in 4% paraformaldehyde and prehybridized by proteinase K digestion (1 ,ug/ml for 10 min). Hybridization with the "S-UTP-labeled antisense probe C was performed at 55°C for 24 h in 60% formamide, 15% dextran sulfate, lx Denhardt's solution, 1 mM EDTA, 10 mM Tris Cl (pH 8), and 400 mM NaCl. Sections were then subjected to RNAse A digestion to remove all nonhybridized single-stranded RNA, washed at stringencies ofup to 0.1 x SSC at 55°C for 30 min, and exposed to photoemulsion at 4°C. The slides were developed 26 d after the emulsion dipping. Cellular expression of mRNA is indicated by the presence of silver grains. "Background" signal was defined as the density of grains on the glass slide, where no tissue was present. To be certain that the hybridization signal was specific for probe C, sequential sections of the same tissue were hybridized under identical conditions using "S-UTP-labeled sense probe C. Using the sense probe C, scattered grains were found over tissue and slide but no specific hybridization signal was ever found. (11) (12) (13) . Sections were first immunostained for a particular antigen using the immunogold silver staining method. The same section was then incubated with a second primary antibody; antigen-antibody complexes were detected by Texas-red-labeled donkey anti-rabbit serum. Slides were then examined under epipolarization and fluorescence microscopy. The immunogold silver staining did not interfere with subsequent immunofluorescent staining.
Results
Ribonuclease protection assays. First, we examined the possibility of detecting a,-AT mRNA in specimens ofhuman intestine by ribonuclease protection assay. A 158-nt cRNA probe that corresponds to a region spanning the downstream "hepatocyte"-specific transcriptional initiation site was used (Fig. 1 ).
The results indicate that there is a single fragment in human jejunum that comigrates with the fragment present in Caco2 cells. The same fragment is present in human hepatoma HepG2 cells and in human liver (7) . There is no evidence of a protected fragment in human colon. The fragment that is protected in human jejunum and Caco2 cells is much smaller than a single fragment present in human peripheral blood monocytes. In other studies, this larger fragment found in cells of mononuclear phagocyte origin, which is fully protected by the probe, has been shown to be derived from transcripts that initiate at upstream alternative transcriptional initiation sites (7) . Examination of three other donors yielded identical results (data not shown). These data provided evidence that a,-AT mRNA could be detected in intestinal specimens with cRNA probe C.
In situ hybridization studies. Next, we examined human liver by in situ hybridization with cRNA probe C to determine that both our previously established technique for in situ hybridization and our probe could be used in the highest a1-ATproducing tissue. Cryostat sections ofnormal human liver were hybridized with 35S-labeled cRNA probe C (Fig. 2) . The A serial cryostat section of human jejunum was hybridized with "S sense cRNA probe C and examined by dark-field microscopy under low (x80) and high (X 125) powers. (E) Specificity of in situ hybridization to a,-AT mRNA in human jejunum. A serial cryostat section of human jejunum was examined by dark-field microscopy under low (X 125) power without any hybridization to cRNA probes. This section was subjected to the same pre-and posthybridization conditions as those for A-D.
demonstrate extensive hybridization to parenchymal cells of the liver with the antisense probe (A and B) as compared to the negligible staining of adjacent liver sections with the sense probe (C and D). These studies established that our in situ hybridization technique with this cRNA probe was specific and, therefore, could be used to examine human intestinal epithelium.
Cryostat sections of human jejunum from an organ donor were hybridized with 35S antisense cRNA probe C (Fig. 3, A  and C) . There was dense localization of silver grains to epithea,-Antitrypsin Expression in Human Enterocytes and Paneth Cells There was also an impression that the density of silver grains increased toward the villus tip. Remarkably, although there were no silver grains in the upper epithelial cells of the crypt, an especially intense accumulation of grains was consistently found at the bases of the crypts (closed arrows). This is shown clearly in a higher power view in Fig. 3 C. On a purely anatomical basis, this domain is usually occupied by Paneth cells. Examination of a second, completely unrelated organ donor yielded identical results (data not shown). The hybridization to villous enterocytes and to cells at the bases ofthe crypts (presumably Paneth cells) with "IS-labeled antisense cRNA probe C was shown to be specific as evidenced by the absence of silver grains in these cells when serial sections ofjejunum were incubated with 35S-labeled "sense" probe C (Fig. 3, B and D) .
As depicted in Fig. 3 , there were also cells in the lamina propria that were prominent because of their refractile properties (open arrows), but did not contain silver grains above background found on the slide. This was seen with both sense and antisense cRNA probes (Fig. 3, A and C) , as well as with sense and antisense cRNA probes for an upstream transcriptional initiation site (data not shown). In fact, these refractile cells can often be seen on dark-field examination, even in sections that have not been subject to in situ hybridization (Fig. 3 E) .
Cryostat sections of human colon from the same donors were also subjected to in situ hybridization (data not shown). Silver grains were not detected in cells lining the epithelium. These observations are consistent with results of ribonuclease protection assays ( Fig. 1 and reference 7) .
Immunohistochemical studies. To determine whether cells within the jejunal crypt epithelium that express a,-AT mRNA might indeed be Paneth cells, we subjected serial sections to immunohistochemical staining with antibodies directed against lysozyme, a protein that is abundantly expressed in Paneth cells (11, 14) , and against a,-AT. First, cryostat sections of human jejunum were incubated with rabbit anti-human lysozyme (Fig. 4 A) or with rabbit anti-human a,-AT (Fig. 4 B) and detected using Texas red-conjugated donkey anti-rabbit sera. There was an intense staining of cells at the base of the crypt epithelium. The region was identical to that which had been specifically detected by in situ hybridization (Fig. 3, A and C) . Next, we used double-label immunocytochemical techniques to determine whether these cells coexpressed aI-AT and lysozyme. Since we planned to use immunogold with silver enhancement and fluorescence for double-antigen detection, we first examined the specificity of the immunogold silver detection system for aI-AT using human liver as positive control (Fig. 5) . The results showed that we could not detect a1-AT in normal liver (A)! but did find it in liver from individuals with homozygous PiZZ a1-AT deficiency, in which a1-AT is known to accumulate within hepatocytes (Fig. 5 B) . There were brown-stained hepatic parenchymal cells scattered through the hepatic lobule but were most prominent adjacent to a broad band of fibrosis. These results are completely consistent with previous immunocytochemical analyses ofhuman liver for a1-AT ( 15). It is unclear why one cannot stain a1-AT in normal human liver, but it has been suggested that the rapid secretion of this protein leads to steady state levels of a1-AT within the liver cells that fall below the limits ofdetection of most immunocytochemical techniques. In contrast, intracellular accumulation of the mutant (Z) a,-AT molecule leads to steady state levels of al-AT within some liver cells that are detectable by immunocytochemical techniques. Thus, these results demonstrate the potential for misleading conclusions when using immunocytochemistry as an indicator of biosynthesis for a,-AT.
In any case, the fact that we could stain a,-AT in a specific manner in the deficient liver using IGSS as the detection system did indicate that it was possible to use this detection system for colocalization studies in human intestinal epithelium. Thus, a cryostat section ofhuman jejunum from one ofthe two organ donors that were used for in situ hybridization was incubated with rabbit anti-human a,-AT and then subjected to immunogold with silver enhancement staining (Fig. 6) . Staining of epithelial cells within the crypt base could be detected by light microscopy (Fig. 6 A) , as well as under reflected light polarization microscopy (Fig. 6 B) . The fact that these cells from a normal human donor can be stained for a,-AT must indicate that they either secrete a,-AT at a slower rate than liver cells, or that there is a higher level of synthesis of a,-AT per cell. In situ hybridization studies in Fig. 3 , A and C are consistent with the latter hypothesis but cannot be used as definitive evidence. The section used for Fig. 6, A and B was then incubated with rabbit anti-human lysozyme and Texas red-conjugated donkey anti-rabbit serum (Fig. 6 C) . An identical region within the crypts stained red, as viewed under fluorescent microscopic examination. A doubly exposed photograph (Fig. 6 D) shows that there is colocalization of Texas red and immunogold staining. These results, therefore, provide further evidence that the a,-AT gene is expressed in Paneth cells.
Intestinal a,-A T gene expression in Crohn 's disease. Next, we examined cryostat sections of inflamed ileum from a patient with Crohn's disease and compared them to sections of adjacent uninflamed ileum from the same patient and to sections ofileum from a normal organ donor. To make the analysis strictly comparable, these sections were hybridized together with the same prep of "S-labeled antisense and sense cRNA probes, washed together, subjected to autoradiography together for the same length of time and photographed together (Fig. 7) . The results indicate that there is hybridization to the epithelial cells ofthe villus in each case but there is an increase in intensity in the inflamed Crohn's ileum (Fig. 7 B) and in adjacent uninflamed Crohn's ileum (Fig. 7 C) as compared to normal ileum (Fig. 7 A) . There were no silver grains in villus epithelial cells using the sense probe, in normal ileum (data not shown), inflamed Crohn's ileum (data not shown), or uninflamed Crohn's ileum (Fig. 7 D) Examination of the crypts showed silver grains in a localized region (closed arrows) in normal ileum (Fig. 7 E) as compared to silver grains which almost completely line the crypt epithelium of inflamed Crohn's ileum (Fig. 7 F) . There is no increase in the length ofthe crypt epithelium from uninflamed Crohn's ileum which hybridizes to the antisense cRNA probe (Fig. 7 G) . There were no silver grains above background in the crypt epithelium with the sense cRNA probe (Fig. 7 H) . There was a qualitative impression that there was less intense hybridization to Paneth cells in the normal ileum than in the normal jejunum. A remarkable increase in inflammatory cells was noted in Crohn's ileum (open arrows). These cells have similar refractile properties as those indicated in Fig. 3 (open arrows) but do not demonstrate a,-AT mRNA, since there are no silver grains overlying them. All of these results were replicated in another series of in situ hybridization analyses with the same normal ileum compared to another inflamed Crohn's ileum (data not shown).
To determine whether a,-AT gene expression in the crypt epithelium of Crohn's ileum was attributable to Paneth cells and/or enterocytes, serial sections from the same specimens were subjected to immunohistochemical analysis for Paneth cells (Fig. 8) . The results indicate that in the normal ileum, there is staining by antibody to lysozyme at the base of the crypts, the usual location of Paneth cells (Fig. 8 A) . In the inflamed Crohn's ileum, staining with antibody to lysozyme extends a considerable distance up the length of the crypt (Fig.  8 B) , but extension up the crypt epithelium is patchy (Fig. 8  C) . In addition, the staining does not extend as far up the length ofthe crypt epithelium as does the specific hybridization with a I-AT antisense cRNA (data not shown). Taken together, these data suggest that there is induction of a,-AT gene expression in crypt enterocytes, as well as expression of a,-AT in proliferating Paneth cells in the crypts of inflamed Crohn's ileum. The induction of a,-AT in crypt enterocytes is great enough to be detected by in situ hybridization analysis but not enough to be detected by immunofluorescence (data not shown). There was no increase in the length of crypt epithelium stained with antibody to lysozyme in the uninflamed Crohn's ileum (Fig. 8 D) .
Discussion
These data establish that the a,-AT gene is expressed in human jejunal and ileal enterocytes in vivo and under physiologic conditions. Previous studies using immunohistochemical techniques, RNA blot analyses, and ribonuclease protection assays to detect cell-specific a,-AT mRNA transcripts had suggested, but could not prove that a,-AT was synthesized in enterocytes (5, 7). Previous in situ hybridization studies had detected a similar distribution of human a1-AT gene expression in the small intestine of mice transgenic for the human a,-AT gene (6) . These animals had been generated with a DNA fragment that spanned the structural gene for a,-AT, -8 kb of its upstream flanking region and -20 kb of its downstream flanking region. Previous immunohistochemical studies had detected a roughly similar distribution of human a1-AT gene expression in the intestine of mice transgenic for a considerably smaller fragment encoding the a1-AT gene (5) . In these mice, a DNA fragment that spanned the structural gene for a1-AT, 2 kb of its upstream flanking region and 2.3 kb of its downstream flanking region was used as transgene. Although our study indicates that it can be misleading to draw conclusions about the expression of this gene from immunocytochemical analyses alone, taken together the above data suggest that the structural elements responsible for expression of the human a1-AT gene in enterocytes and Paneth cells are localized within 2 kb upstream and 2.3 kb downstream of the a,-AT structural gene. Moreover, the data indicate that transacting factors and/or mechanisms that are required for the same spatial distribution of human a,-AT gene expression are conserved from the mouse to the human system, even though there is no evidence for expression of the murine a1-AT gene in the small intestine.
The results of this study indicate that the expression of the a,-AT gene in the human intestinal adenocarcinoma cell line Caco2 reflects physiologic expression in the small intestine. There was no evidence for a1-AT mRNA in colonic epithelial cells or in small intestinal crypt epithelial cells other than Paneth cells, but a,-AT mRNA was detected in small intestinal villous epithelial cells. We have previously shown that there is a marked increase in expression ofthe a, -AT gene during differentiation of Caco2 cells from crypt-like to villous-like enterocytes (7, 9) . The differentiation-dependent increase in Caco2 cell a1-AT gene expression could also represent a recapitulation of late fetal development as suggested by the expression of a-fetoprotein in the cell line. The initiation site for transcription of the a,-AT mRNA in jejunum is identical to that of differentiated Caco2 cells (7) . The increase in a1-AT gene expression in epithelial cells of inflamed intestine from a patient with Crohn's disease is also of great interest. We have recently found that the acute phase cytokine interleukin-6 mediates an increase in a,-AT gene expression in Caco2 cells ( 16) . Moreover, other cytokines mediate induction or upregulation of the expression of many ofthe positive acute phase reactants in Caco2 cells and do so in a manner that is almost identical to that which occurs in liver cells in the plasma during the host response to inflammation in vivo. For instance, IL-13 and IL-6 induce the synthesis of serum amyloid A and a,-ACT, increase synthesis of complement proteins factor B and C3, increase synthesis ofceruloplasmin while leading to decreased synthesis of transferrin and afetoprotein ( 16) . IFN-y mediates an increase in complement protein C4 in Caco2 cells. These effects may be particularly relevant to Crohn's disease in that Ahrenstedt et al. have shown that there is increased local production offactors B, C3, and C4 in uninvolved intestine of patients with Crohn's disease, actively affecting other segments of bowel ( 17) .
Results of this study also raise the possibility that fecal a,-AT quantitation for the diagnosis ofprotein-losing enteropathy ( 18) actually measures al-AT derived from intestinal epithelial cells. We have previously shown that Caco2-derived enterocytes secrete a1-AT into the apical (luminal) fluid, as well as into the basolateral fluid. Even more important in this regard, however, is a1-AT within the continuously sloughed enterocytes. Enterocytes are sloughed from the tip ofthe villus -3 d after initiating migration at the base ofthe villus ( 17) , and it is widely believed that the rate of sloughing increases during conditions in which there is local inflammation/injury. A study by Taken together with the current study, this observation makes it likely that a1-AT in feces is largely derived from a,-AT in sloughed enterocytes and unlikely that it diffuses or leaks into the intestinal lumen from the bloodstream. The increase in fecal a1-AT demonstrated in various protein-losing enteropathies could, in turn, represent the effect of small intestinal inflammation on the enterocyte extrusion rate.
It is also probable that a,-AT is expressed in the intestinal epithelium by resident macrophages. Previous studies have shown that blood monocytes and macrophages from two other tissues, respiratory epithelium and breast epithelium, synthesize a,-AT (4) . Nevertheless, it was not possible to definitively demonstrate expression of the a,-AT gene in macrophages of the intestine by in situ hybridization because of the relatively high background. Ribonuclease protection assays have also been unable to detect macrophage-specific a,-AT transcripts in human intestinal homogenates, probably because of the relatively low numbers of macrophages ordinarily present in this tissue on a per unit area basis (7). Moreover, our recent studies have indicated that transcripts initiated at the alternative upstream, so-called "macrophage-specific" initiation sites may be detected in Caco2-derived enterocytes activated by interleukin-6 (7). Thus, even if these transcripts derived from the upstream alternative "macrophage-specific" initiation sites were detected by ribonuclease protection assays, it would not exclude the possibility that they were derived from activated enterocytes.
One of the most striking results of this study is the intense hybridization to a,-AT mRNA in Paneth cells. Several recent observations have led to greater understanding of this apparently highly specialized cell type. First, it is known that Paneth cells are derived from the same multipotent stem cell that also gives rise to enterocytes, goblet cells, and enteroendocrine cells (21) (22) (23) (24) (25) (26) (27) . Enterocytes and goblet cells arise as they are rapidly translocated to the apical extrusion zone. Paneth cells differentiate as they descend to the base of the crypt. Second, several observations have suggested that Paneth cells play a role in host defense at the mucosal surface. In the rat, Paneth cells have been shown to have phagocytic activity against at least two different species of intestinal microorganisms ( 14) . Lysozyme, an enzyme found in mononuclear phagocytes and that has antibacterial properties, has been detected in secretory granules of mature Paneth cells (28, 29) . It has been considered a specific marker of these cells. Cryptidin, a peptide that is related to the defensins of classical phagocytic cells, has been specifically localized to Paneth cells (30) . The appearance of cryptidin mRNA in mouse small bowel coincides with gut closure and with the establishment of a barrier to bacterial translocation; therefore, it has been implicated in antibacterial activity. Paneth cells are also similar to other phagocytic cells in that they express TNF-a (31) . Paneth cells have recently been shown to be the site of expression within the intestine for guanylin (32), a peptide which represents the endogenous ligand for the intestine-specific receptor guanylyl cyclase (33) . Expression of guanylin may be the most important function ofPaneth cells in that the heat-stable enterotoxins of Escherichia coli and Yersinia are thought to induce diarrhea by competing with guanylin for binding to guanylyl cyclase (34) . Third, Paneth cells may play a role in enzymatic digestion of luminal nutrients.
There are abundant carboxylic ester hydrolases in secretory granules of Paneth cells, similar to those ofpancreatic exocrine cells (35, 36) . Expression of a,-AT, a molecule that is capable of inhibiting bacterial serine proteases, as well as certain digestive proteases, and which otherwise plays an important role in the host response to inflammation/tissue injury, may therefore be especially relevant to the Paneth cell.
